Novartis AG

Novartis is a multinational pharmaceutical company that researches, develops, manufactures and markets a broad portfolio of innovative medicines, generic drugs and consumer health products. Its therapeutic areas include oncology, immunology, neuroscience, cardiovascular and metabolism, as well as ophthalmology and respiratory diseases. The company also produces vaccines and over‑the‑counter health items that are distributed to hospitals, pharmacies and retail outlets in both developed and emerging markets. Novartis serves patients worldwide by addressing unmet medical needs through its science‑driven approach to drug discovery and development.

Headquartered in Basel, Switzerland, Novartis operates as a global enterprise with subsidiaries, research sites and manufacturing facilities located across Europe, North America, Asia and other regions. The company is recognized as one of the largest pharmaceutical firms in the world, employing a substantial workforce that supports its extensive research and commercial activities. Its presence spans many countries, allowing it to reach diverse patient populations and adapt to local regulatory environments. Novartis maintains a strong commitment to quality and safety, which is reflected in its compliance with international standards such as those set by the FDA and EMA.

A distinguishing attribute of Novartis is its emphasis on innovative medicines backed by a robust research and development pipeline that has delivered numerous breakthrough therapies in areas such as cancer immunotherapy and gene‑based treatments. The company also runs Sandoz, a leading generics division, and a consumer health business that offers widely used over‑the‑counter products. In addition to its scientific expertise, Novartis places high importance on data protection and cybersecurity, as demonstrated by its response to the 2022 incident where it confirmed that no sensitive data was compromised and highlighted its adherence to privacy standards through implemented security measures. This focus on safeguarding information complements its regulatory obligations and reinforces trust among stakeholders.

Structurally, Novartis AG is the parent entity of the Novartis Group and is publicly traded on the SIX Swiss Exchange and the New York Stock Exchange, with ownership dispersed among institutional and individual shareholders. The group comprises several business units and subsidiaries that operate under a unified corporate governance framework designed to ensure accountability and strategic alignment. This structure enables Novartis to coordinate global research initiatives while allowing regional units to tailor commercial approaches to local market needs.